Speaker illustration

Professor Sripal Bangalore

New York University School of Medicine, New York (United States of America)

Dr. Bangalore is an interventional cardiologist and a Professor of Medicine with tenure at New York University School of Medicine. He is the Director of invasive and interventional cardiology, Director of Complex Coronary Intervention and Interventional Director, Adult ECMO, MCS and PERT Program at Bellevue Hospital; Director of Research for the cardiac catheterization laboratory at NYU Langone Medical Center. His clinical expertise is in complex coronary intervention including CTOs, ultra low volume/zero contrast PCI, mechanical circulatory support and PERT. His research interests are in comparative effectiveness studies for stable ischemic heart disease, acute coronary syndromes, and hypertension. Dr. Bangalore has received grants from the National Institutes of Health, Agency for Healthcare Research and Quality, American Heart Association and from the industry. He is on writing committee for the ACC/AHA/SCAI revascularization guidelines.

Risk stratification of intermediate risk pulmonary embolism: importance of normotensive shock

Event: ESC Congress 2023

Topic: Acute Pulmonary Embolism

Session: Why does an expanding data and product portfolio position lytic-free thrombectomy as the first choice for acute pulmonary embolism (PE) treatment?

Thumbnail

Is complete revascularisation still the goal in chronic coronary syndrome interventions?

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session: The ISCHEMIA trial: unanswered questions

Thumbnail

The essence of ISCHEMIA: when and why should we revascularise?

Event: ESC Congress 2022

Topic: Revascularisation

Session: Coronary revascularisation – state of the art for chronic coronary syndromes

Thumbnail

Preventive anticoagulation.

Event: ESC Congress 2022

Topic: Cardiovascular Disease in Special Populations

Session: Cardiovascular update and COVID-19

Thumbnail

ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up.

Event: ESC Congress 2022

Topic: Revascularisation

Session: HOT LINE SESSION 8

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb